سمر محمود محمد الباهى
مدرس
Expression of NCF4 (rs1883112) polymorphism and risk of developing Acute Lymphoblastic Leukemia in Egyptian children
• 2025
معلومات البحث
المؤلفون
Walid Abdellatif Abdelhalim1, Amira M. N. Abdelrahman1, Adel Marzouk Agha1, Samar Mahmoud Elbahy2, Amr Fathy Mohamed Gad1, Maha M. T. Rashwan1
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
Local
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Background: Acute lymphoblastic leukemia (ALL) incidence has been linked to different genetic variations. Neutrophil cytosolic factor 4 (NCF4) (rs1883112) single nucleotide polymorphism (SNP) is one of the implicated genetic variations.
Aim: To demonstrate the association between NCF4 (rs1883112) SNP and susceptibility to develop ALL in Egyptian children and its correlation to clinical variables, laboratory parameters, and patient outcomes.
Methods: The study was conducted on 100 ALL patients < 18 years old and 100 healthy controls matched in age and sex. The detection of NCF4 (rs1883112) polymorphism by Taqman real-time PCR was carried out.
Results: The GA and AA genotypes, dominant model, and A allele showed a lower frequency in ALL patients compared to controls (p=0.001, 0.015, 0.001, and 0.009, respectively). The AA genotype was significantly associated with a higher frequency of patients with t(12;21), and those achieved complete remission (p=0.005 and 0.014, respectively). The hazard ratio (HR) of the dominant model was (HR=0.15, p=0.031) for overall survival and (HR=0.24, p=0.012) for disease-free survival by univariate analysis.
Conclusion: Our results suggested that NCF4 (rs1883112) SNP has a significant protective effect against susceptibility to ALL development. Also it is associated with favorable outcomes concerning the overall survival and disease-free survival.
Aim: To demonstrate the association between NCF4 (rs1883112) SNP and susceptibility to develop ALL in Egyptian children and its correlation to clinical variables, laboratory parameters, and patient outcomes.
Methods: The study was conducted on 100 ALL patients < 18 years old and 100 healthy controls matched in age and sex. The detection of NCF4 (rs1883112) polymorphism by Taqman real-time PCR was carried out.
Results: The GA and AA genotypes, dominant model, and A allele showed a lower frequency in ALL patients compared to controls (p=0.001, 0.015, 0.001, and 0.009, respectively). The AA genotype was significantly associated with a higher frequency of patients with t(12;21), and those achieved complete remission (p=0.005 and 0.014, respectively). The hazard ratio (HR) of the dominant model was (HR=0.15, p=0.031) for overall survival and (HR=0.24, p=0.012) for disease-free survival by univariate analysis.
Conclusion: Our results suggested that NCF4 (rs1883112) SNP has a significant protective effect against susceptibility to ALL development. Also it is associated with favorable outcomes concerning the overall survival and disease-free survival.